About: Deactivation of vascular endothelium by monoclonal anti-tumor necrosis factor alpha antibody in rheumatoid arthritis

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Deactivation of vascular endothelium by monoclonal anti-tumor necrosis factor alpha antibody in rheumatoid arthritis Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 July 1996

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в липні 1996 (uk) im Juli 1996 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xunetu de 1996 (ast) scientific article published on 01 July 1996 (en)
publication date	wds:Q71160288-23348749-81C8-42B4-8BB0-EC9682B74B5B
publication date	1996-07-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q71160288-2981C8BB-DDC0-40D2-96D2-019FEDD81E59 wds:Q71160288-35EA3A2A-7642-4C38-A19D-8F29981660D4 wds:Q71160288-4FFB891F-02DC-46D6-BB69-1FCEC4ED03E2 wds:Q71160288-62663D63-55B0-496C-8432-B5585B797112 wds:Q71160288-92731F41-E00E-48AE-A4FA-0CCBD1E19954 wds:Q71160288-D3532A67-9083-4546-9C40-B69BC5A002DA
author name string	M Feldmann R N Maini M Hunt E M Paleolog J N Woody M J Elliott
rdfs:label	Deactivation of vascular endothelium by monoclonal anti-tumor necrosis factor alpha antibody in rheumatoid arthritis (en) Deactivation of vascular endothelium by monoclonal anti-tumor necrosis factor alpha antibody in rheumatoid arthritis (nl)
skos:prefLabel	Deactivation of vascular endothelium by monoclonal anti-tumor necrosis factor alpha antibody in rheumatoid arthritis (en) Deactivation of vascular endothelium by monoclonal anti-tumor necrosis factor alpha antibody in rheumatoid arthritis (nl)
name	Deactivation of vascular endothelium by monoclonal anti-tumor necrosis factor alpha antibody in rheumatoid arthritis (en) Deactivation of vascular endothelium by monoclonal anti-tumor necrosis factor alpha antibody in rheumatoid arthritis (nl)
title	wds:Q71160288-10ABFDE8-469A-4689-81CA-1AD500FEA676
title	Deactivation of vascular endothelium by monoclonal anti-tumor necrosis factor alpha antibody in rheumatoid arthritis (en)
page(s)	wds:Q71160288-506A26D2-6C47-4CD2-A6CF-800FB6CD733C
page(s)	1082-1091
instance of	wds:Q71160288-833D1DE2-1B3D-4740-91AC-C0720E6AF269
instance of	scholarly article
main subject	wds:Q71160288-2A352126-BB76-46A9-AE7D-10720BE4E72E
main subject	rheumatoid arthritis
PubMed ID	wds:Q71160288-E8BE8786-C639-4F5B-B04E-071EA341A3CB
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8670315
PubMed ID	8670315
published in	wds:Q71160288-F48BA977-EF48-41E0-89E1-EC947FE89DE3
published in	Arthritis and Rheumatism
issue	wds:Q71160288-065DD588-5186-440F-B936-3C447E341EF2
volume	wds:Q71160288-31CE9AF3-70AA-4A2D-AA11-B816B9928EB5
issue	7
volume	39
DOI	wds:Q71160288-24A2A1C9-F3E3-4A39-801D-A665D4CCF936
DOI	http://dx.doi.org/10.1002/ART.1780390703
DOI	10.1002/ART.1780390703
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q71160288
is cites work of	Infliximab treatment induces apoptosis of lamina propria T lymphocytes in Crohn's disease. Development of anti-TNF therapy for rheumatoid arthritis Infection complications associated with the use of biologic agents Efficient adenoviral infection with IkappaB alpha reveals that macrophage tumor necrosis factor alpha production in rheumatoid arthritis is NF-kappaB dependent Seeing the wood for the trees: the forgotten role of neutrophils in rheumatoid arthritis Anti-TNF therapy for rheumatoid arthritis and other inflammatory diseases Selectins, T-cell rolling and inflammation A new role for the anti-apoptotic gene A20 in angiogenesis Infliximab: a review of its use in the management of rheumatoid arthritis Severe inflammatory arthritis and lymphadenopathy in the absence of TNF. Adhesion molecules in inflammatory diseases Cells of the synovium in rheumatoid arthritis. Dendritic cells. Cytokines in autoimmunity Cytokines in rheumatoid arthritis. Potential targets for pharmacological intervention. Immunomodulatory effects of granulocyte and monocyte adsorption apheresis as a treatment for patients with ulcerative colitis Regulation of angiogenesis by the C-X-C chemokines interleukin-8 and epithelial neutrophil activating peptide 78 in the rheumatoid joint The future role of anti-tumour necrosis factor (TNF) products in the treatment of rheumatoid arthritis Rheumatoid arthritis synovium contains plasmacytoid dendritic cells Deactivation of endothelium and reduction in angiogenesis in psoriatic skin and synovium by low dose infliximab therapy in combination with stable methotrexate therapy: a prospective single-centre study Anti-tumour necrosis factor specific antibody (infliximab) treatment provides insights into the pathophysiology of rheumatoid arthritis Increased peripheral T cell reactivity to microbial antigens and collagen type II in rheumatoid arthritis after treatment with soluble TNFalpha receptors Cytokines in immunotherapy of experimental uveitis Sustained changes in lipid profile and macrophage migration inhibitory factor levels after anti-tumour necrosis factor therapy in rheumatoid arthritis Fucosyltransferase 1 mediates angiogenesis, cell adhesion and rheumatoid arthritis synovial tissue fibroblast proliferation Gene expression profiling in the synovium identifies a predictive signature of absence of response to adalimumab therapy in rheumatoid arthritis Monoclonal antibody therapy Tumor necrosis factor alpha plays a central role in immune-mediated clearance of adenoviral vectors Tumor necrosis factor or tumor promoting factor? A novel mechanism of neutrophil recruitment in a coculture model of the rheumatoid synovium TNFalpha blockade in human diseases: mechanisms and future directions Rheumatoid arthritis. From bench to bedside Angiogenesis as a target in rheumatoid arthritis Persistence of interleukin 7 activity and levels on tumour necrosis factor alpha blockade in patients with rheumatoid arthritis New vessels, new approaches: angiogenesis as a therapeutic target in musculoskeletal disorders Effects of treatment with a fully human anti-tumour necrosis factor alpha monoclonal antibody on the local and systemic homeostasis of interleukin 1 and TNFalpha in patients with rheumatoid arthritis. Long term anti-tumour necrosis factor alpha monotherapy in rheumatoid arthritis: effect on radiological course and prognostic value of markers of cartilage turnover and endothelial activation. Treatment with monoclonal anti-tumor necrosis factor alpha antibody results in an accumulation of Th1 CD4+ T cells in the peripheral blood of patients with rheumatoid arthritis Gene expression profile and synovial microcirculation at early stages of collagen-induced arthritis Pneumocystis jiroveci (carinii) pneumonia after infliximab therapy: a review of 84 cases Pharmacological modulation of cell adhesion molecules Suppression of endothelial cell activity by inhibition of TNFα A follow-up to "Anti-cytokine therapy in chronic destructive arthritis" by Wim B van den Berg The impact of cytokines on the expression of drug transporters, cytochrome P450 enzymes and chemokine receptors in human PBMC. Monocyte migration to the synovium in rheumatoid arthritis patients treated with adalimumab Angiogenesis in rheumatoid arthritis: implications for future therapeutic strategies Anti-tumor necrosis factor-alpha therapy with infliximab as an alternative to corticosteroids in the treatment of human leukocyte antigen B27-associated acute anterior uveitis How does infliximab work in rheumatoid arthritis? Synovial tissue response to treatment in rheumatoid arthritis Cytokine and chemokine receptor profile of peripheral blood mononuclear cells during treatment with infliximab in patients with active rheumatoid arthritis Long-term follow-up of the changes in circulating cytokines, soluble cytokine receptors, and white blood cell subset counts in patients with rheumatoid arthritis (RA) after monoclonal anti-TNF alpha antibody therapy TCRzetadim lymphocytes define populations of circulating effector cells that migrate to inflamed tissues Phenotypic characteristics of human monocytes undergoing transendothelial migration Anti-tumor necrosis factor-alpha monoclonal antibody therapy for rheumatoid arthritis

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 193 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software